A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
Clinical trial NCT03615482 · COMPLETED
Trial details
- NCT number
- NCT03615482
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-14
- Primary completion
- 2019-06-24
- Enrollment
- 1200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.